Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial

Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schizophrenia research 2017-06, Vol.184, p.145-146
Hauptverfasser: Rahmanzadeh, Reza, Eftekhari, Sanaz, Shahbazi, Ali, Khodaei Ardakani, Mohammad-reza, Rahmanzade, Ramin, Mehrabi, Soraya, Barati, Mahmood, Joghataei, Mohammad Taghi
Format: Artikel
Sprache:eng
Schlagworte:
Psychiatry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146
container_issue
container_start_page 145
container_title Schizophrenia research
container_volume 184
creator Rahmanzadeh, Reza
Eftekhari, Sanaz
Shahbazi, Ali
Khodaei Ardakani, Mohammad-reza
Rahmanzade, Ramin
Mehrabi, Soraya
Barati, Mahmood
Joghataei, Mohammad Taghi
description
doi_str_mv 10.1016/j.schres.2016.12.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852665576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996416305606</els_id><sourcerecordid>1852665576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-5f24a876d355ea1988417abcbeac8e213ae5a5c6836d60d9100a640576bb67b13</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCILoV_gJCPHJpgO7GTCAmpWpUPUcEBOFv-mGi9eO3FTiq1v4CfzUTbcuDCyfL4vTfj96aqXjLaMMrkm31T7C5DaTjeGsYbSvmjasNE39Zc0PFxtaEjp_U4yu6selbKnlLKBO2fVme8H4WkdNhUv6-mCexM0kTMcoBZR-_ggmhSIGDd3wD58nm7ZcTHnTd-TvmCpEh2OoTF-qhnn2JZ2TiMv0tHnCh6S474AHEub1HJpcUEqE3w0ZGso0sHfweOWCx4qwOZs9fhefVk0qHAi_vzvPrx_ur79mN9_fXDp-3ldW071s-1mHinh166VgjQbBwGLGtjDWg7AGetBqGFlUMrnaRuZJRq2VHRS2Nkb1h7Xr0-6R5z-rVAmdXBFwsh6AhpKYoNgkspkIDQ7gS1OZWSYVLH7A863ypG1ZqB2qtTBmrNQDGuMAOkvbrvsJgDuL-kB9MR8O4EAPznjYeMKuiWBeczeq5c8v_r8K_Ag5c_4RbKPi05ooeKqYIE9W3dg3UNmGwpjiDbP0V4sCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852665576</pqid></control><display><type>article</type><title>Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial</title><source>Access via ScienceDirect (Elsevier)</source><creator>Rahmanzadeh, Reza ; Eftekhari, Sanaz ; Shahbazi, Ali ; Khodaei Ardakani, Mohammad-reza ; Rahmanzade, Ramin ; Mehrabi, Soraya ; Barati, Mahmood ; Joghataei, Mohammad Taghi</creator><creatorcontrib>Rahmanzadeh, Reza ; Eftekhari, Sanaz ; Shahbazi, Ali ; Khodaei Ardakani, Mohammad-reza ; Rahmanzade, Ramin ; Mehrabi, Soraya ; Barati, Mahmood ; Joghataei, Mohammad Taghi</creatorcontrib><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2016.12.002</identifier><identifier>PMID: 27956008</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Psychiatry</subject><ispartof>Schizophrenia research, 2017-06, Vol.184, p.145-146</ispartof><rights>Elsevier B.V.</rights><rights>2016 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-5f24a876d355ea1988417abcbeac8e213ae5a5c6836d60d9100a640576bb67b13</citedby><cites>FETCH-LOGICAL-c417t-5f24a876d355ea1988417abcbeac8e213ae5a5c6836d60d9100a640576bb67b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.schres.2016.12.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27956008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahmanzadeh, Reza</creatorcontrib><creatorcontrib>Eftekhari, Sanaz</creatorcontrib><creatorcontrib>Shahbazi, Ali</creatorcontrib><creatorcontrib>Khodaei Ardakani, Mohammad-reza</creatorcontrib><creatorcontrib>Rahmanzade, Ramin</creatorcontrib><creatorcontrib>Mehrabi, Soraya</creatorcontrib><creatorcontrib>Barati, Mahmood</creatorcontrib><creatorcontrib>Joghataei, Mohammad Taghi</creatorcontrib><title>Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><subject>Psychiatry</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFUk1v1DAQjRCILoV_gJCPHJpgO7GTCAmpWpUPUcEBOFv-mGi9eO3FTiq1v4CfzUTbcuDCyfL4vTfj96aqXjLaMMrkm31T7C5DaTjeGsYbSvmjasNE39Zc0PFxtaEjp_U4yu6selbKnlLKBO2fVme8H4WkdNhUv6-mCexM0kTMcoBZR-_ggmhSIGDd3wD58nm7ZcTHnTd-TvmCpEh2OoTF-qhnn2JZ2TiMv0tHnCh6S474AHEub1HJpcUEqE3w0ZGso0sHfweOWCx4qwOZs9fhefVk0qHAi_vzvPrx_ur79mN9_fXDp-3ldW071s-1mHinh166VgjQbBwGLGtjDWg7AGetBqGFlUMrnaRuZJRq2VHRS2Nkb1h7Xr0-6R5z-rVAmdXBFwsh6AhpKYoNgkspkIDQ7gS1OZWSYVLH7A863ypG1ZqB2qtTBmrNQDGuMAOkvbrvsJgDuL-kB9MR8O4EAPznjYeMKuiWBeczeq5c8v_r8K_Ag5c_4RbKPi05ooeKqYIE9W3dg3UNmGwpjiDbP0V4sCQ</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Rahmanzadeh, Reza</creator><creator>Eftekhari, Sanaz</creator><creator>Shahbazi, Ali</creator><creator>Khodaei Ardakani, Mohammad-reza</creator><creator>Rahmanzade, Ramin</creator><creator>Mehrabi, Soraya</creator><creator>Barati, Mahmood</creator><creator>Joghataei, Mohammad Taghi</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial</title><author>Rahmanzadeh, Reza ; Eftekhari, Sanaz ; Shahbazi, Ali ; Khodaei Ardakani, Mohammad-reza ; Rahmanzade, Ramin ; Mehrabi, Soraya ; Barati, Mahmood ; Joghataei, Mohammad Taghi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-5f24a876d355ea1988417abcbeac8e213ae5a5c6836d60d9100a640576bb67b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahmanzadeh, Reza</creatorcontrib><creatorcontrib>Eftekhari, Sanaz</creatorcontrib><creatorcontrib>Shahbazi, Ali</creatorcontrib><creatorcontrib>Khodaei Ardakani, Mohammad-reza</creatorcontrib><creatorcontrib>Rahmanzade, Ramin</creatorcontrib><creatorcontrib>Mehrabi, Soraya</creatorcontrib><creatorcontrib>Barati, Mahmood</creatorcontrib><creatorcontrib>Joghataei, Mohammad Taghi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahmanzadeh, Reza</au><au>Eftekhari, Sanaz</au><au>Shahbazi, Ali</au><au>Khodaei Ardakani, Mohammad-reza</au><au>Rahmanzade, Ramin</au><au>Mehrabi, Soraya</au><au>Barati, Mahmood</au><au>Joghataei, Mohammad Taghi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>184</volume><spage>145</spage><epage>146</epage><pages>145-146</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27956008</pmid><doi>10.1016/j.schres.2016.12.002</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0920-9964
ispartof Schizophrenia research, 2017-06, Vol.184, p.145-146
issn 0920-9964
1573-2509
language eng
recordid cdi_proquest_miscellaneous_1852665576
source Access via ScienceDirect (Elsevier)
subjects Psychiatry
title Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T03%3A32%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20bumetanide,%20a%20selective%20NKCC1%20inhibitor,%20on%20hallucinations%20of%20schizophrenic%20patients;%20a%20double-blind%20randomized%20clinical%20trial&rft.jtitle=Schizophrenia%20research&rft.au=Rahmanzadeh,%20Reza&rft.date=2017-06-01&rft.volume=184&rft.spage=145&rft.epage=146&rft.pages=145-146&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2016.12.002&rft_dat=%3Cproquest_cross%3E1852665576%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1852665576&rft_id=info:pmid/27956008&rft_els_id=S0920996416305606&rfr_iscdi=true